The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 04, 2021
Filed:
Jan. 03, 2018
Applicant:
H. Lundbeck A/s, Valby, DK;
Inventors:
Jan Torleif Pedersen, Valby, DK;
Lars Østergaard Pedersen, Valby, DK;
Justus Claus Daechsel, Valby, DK;
Ayodeji Abdur-Rasheed Asuni, Valby, DK;
Nina Helen Rosenqvist, Valby, DK;
Assignee:
H. Lundbeck A/S, Valby, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); C07K 14/435 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61P 25/28 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61P 25/28 (2018.01); G01N 33/6896 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract
The present invention is based on antibodies which are both highly specific for hyperphosphorylated pathogenic P-S396 tau and highly specific for labelled sections of the human retina, as well as to methods of using these antibodies and their tau binding fragments in the treatment of retinoid amyloidosis, age related macular degeneration (ARMD), and glaucoma.
Pedersen, Jan. (2021). Antibodies specific for hyperphosphorlated tau for the treatment of ocular diseases (U.S. Patent No. 10995137). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10995137
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile